Page last updated: 2024-09-04

atractylenolide iii and Angiogenesis, Pathologic

atractylenolide iii has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, R; Fu, J; Ke, X; Liu, T; Lu, H; Ma, J; Wang, S1

Other Studies

1 other study(ies) available for atractylenolide iii and Angiogenesis, Pathologic

ArticleYear
The natural compound codonolactone impairs tumor induced angiogenesis by downregulating BMP signaling in endothelial cells.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2015, Oct-15, Volume: 22, Issue:11

    Topics: Angiogenesis Inhibitors; Animals; Aorta; Atractylodes; Bone Morphogenetic Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Core Binding Factor Alpha 1 Subunit; Human Umbilical Vein Endothelial Cells; Humans; In Vitro Techniques; Lactones; Male; Matrix Metalloproteinases; Neovascularization, Pathologic; Rats, Sprague-Dawley; Sesquiterpenes; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2015